Covid-19 and risk of acute pancreatitis: What beyond

Affiliations

¹ Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
² Department of Science and Engineering, Novel Global Community Educational Foundation, New South Wales, Australia.
³ AFNP Med, Wien, Austria.
⁴ Department of Surgery II, University Hospital Witten-Herdecke, Heusnerstrasse 40, University of Witten-Herdecke, Wuppertal, Germany.
⁵ Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
⁶ Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.

Comment

Hayder M Al-Kuraishy et al. J Cell Mol Med. 2024 Jan.

. 2024 Jan;28(1):e18082.

doi: 10.1111/jcmm.18082. Epub 2023 Dec 15.

¹ Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
² Department of Science and Engineering, Novel Global Community Educational Foundation, New South Wales, Australia.
³ AFNP Med, Wien, Austria.
⁴ Department of Surgery II, University Hospital Witten-Herdecke, Heusnerstrasse 40, University of Witten-Herdecke, Wuppertal, Germany.
⁵ Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
⁶ Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

COVID-19 and acute pancreatitis: examining the causality.
de-Madaria E, Capurso G. de-Madaria E, et al. Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):3-4. doi: 10.1038/s41575-020-00389-y. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33203968 Free PMC article. Review.

1. De Madaria E, Capurso G. COVID‐19 and acute pancreatitis: examining the causality. Nature reviews. Gastroenterol Hepatol. 2021;18(1):3‐4. - PMC - PubMed
1. Pandanaboyana S, Moir J, Leeds JS, et al. SARS‐CoV‐2 infection in acute pancreatitis increases disease severity and 30‐day mortality: COVID PAN collaborative study. Gut. 2021;70(6):1061‐1069. - PMC - PubMed
1. El‐Saber Batiha G, Al‐Gareeb AI, Saad HM, Al‐Kuraishy HM. COVID‐19 and corticosteroids: a narrative review. Inflammopharmacology. 2022;1‐17:1189‐1205. - PMC - PubMed
1. Mostafa‐Hedeab G, Al‐Kuraishy HM, Al‐Gareeb AI, Jeandet P, Saad HM, Batiha GE‐S. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid‐19. Inflammopharmacology. 2022;30:1‐11. - PMC - PubMed
1. Karaali R, Topal F. Evaluating the effect of SARS‐Cov‐2 infection on prognosis and mortality in patients with acute pancreatitis. Am J Emerg Med. 2021;49:378‐384. - PMC - PubMed